LRRC75B
gene geneOn this page
Also known as MGC131773
Summary
LRRC75B (leucine rich repeat containing 75B, HGNC:33155) is a protein-coding gene on chromosome 22q11.23, encoding Leucine-rich repeat-containing protein 75B (Q2VPJ9). May suppress myogenic differentiation by modulating MYOG expression and Erk1/2 signaling.
At a glance
- GWAS associations: 4
- Clinical variants (ClinVar): 1 total
- MANE Select transcript:
NM_207644
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:33155 |
| Approved symbol | LRRC75B |
| Name | leucine rich repeat containing 75B |
| Location | 22q11.23 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | MGC131773 |
| Ensembl gene | ENSG00000178026 |
| Ensembl biotype | protein_coding |
| Entrez | 388886 |
Gene structure
Transcript identifiers
Ensembl transcripts: 11 — 4 protein_coding, 3 retained_intron, 2 nonsense_mediated_decay, 2 protein_coding_CDS_not_defined
ENST00000318753, ENST00000404045, ENST00000446942, ENST00000460524, ENST00000464490, ENST00000465334, ENST00000491910, ENST00000495297, ENST00000876360, ENST00000876361, ENST00000935984
RefSeq mRNA: 1 — MANE Select: NM_207644
NM_207644
CCDS: CCDS42991
Canonical transcript exons
ENST00000318753 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001753854 | 24592863 | 24593073 |
| ENSE00003458221 | 24585635 | 24586411 |
| ENSE00003579732 | 24588214 | 24588329 |
| ENSE00003649609 | 24589821 | 24589949 |
Expression profiles
Bgee: expression breadth ubiquitous, 212 present calls, max score 95.69.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 4.1976 / max 65.6521, expressed in 1412 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 193387 | 4.1976 | 1412 |
Top tissues by expression
228 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| kidney epithelium | UBERON:0004819 | 95.69 | silver quality |
| parotid gland | UBERON:0001831 | 93.66 | silver quality |
| vena cava | UBERON:0004087 | 93.33 | silver quality |
| right lobe of liver | UBERON:0001114 | 93.25 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 93.08 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 92.83 | gold quality |
| thyroid gland | UBERON:0002046 | 92.72 | gold quality |
| lateral nuclear group of thalamus | UBERON:0002736 | 91.79 | silver quality |
| lateral globus pallidus | UBERON:0002476 | 91.65 | silver quality |
| lower esophagus mucosa | UBERON:0035834 | 90.63 | gold quality |
| body of tongue | UBERON:0011876 | 90.46 | silver quality |
| ventral tegmental area | UBERON:0002691 | 89.85 | silver quality |
| pons | UBERON:0000988 | 89.81 | silver quality |
| tongue | UBERON:0001723 | 89.70 | silver quality |
| pharyngeal mucosa | UBERON:0000355 | 89.61 | silver quality |
| trachea | UBERON:0003126 | 89.46 | silver quality |
| metanephros cortex | UBERON:0010533 | 89.41 | gold quality |
| pylorus | UBERON:0001166 | 89.16 | silver quality |
| medulla oblongata | UBERON:0001896 | 88.86 | silver quality |
| substantia nigra pars compacta | UBERON:0001965 | 88.83 | silver quality |
| superior vestibular nucleus | UBERON:0007227 | 88.77 | silver quality |
| ventricular zone | UBERON:0003053 | 88.66 | gold quality |
| cerebellar vermis | UBERON:0004720 | 88.56 | gold quality |
| prostate gland | UBERON:0002367 | 88.52 | gold quality |
| inferior vagus X ganglion | UBERON:0005363 | 88.42 | silver quality |
| trigeminal ganglion | UBERON:0001675 | 88.41 | silver quality |
| tibial nerve | UBERON:0001323 | 88.39 | gold quality |
| superior surface of tongue | UBERON:0007371 | 88.35 | silver quality |
| fundus of stomach | UBERON:0001160 | 88.34 | gold quality |
| dorsal root ganglion | UBERON:0000044 | 88.06 | silver quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 3.08 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
9 targeting LRRC75B, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-636 | 99.80 | 69.58 | 1500 |
| HSA-MIR-6757-3P | 99.63 | 66.88 | 1089 |
| HSA-MIR-4663 | 99.62 | 65.33 | 957 |
| HSA-MIR-6794-3P | 98.76 | 66.99 | 894 |
| HSA-MIR-637 | 97.91 | 64.05 | 1517 |
| HSA-MIR-7112-3P | 97.67 | 68.77 | 948 |
| HSA-MIR-125B-2-3P | 96.69 | 68.38 | 1210 |
| HSA-MIR-668-3P | 96.18 | 65.80 | 673 |
| HSA-MIR-6785-3P | 86.75 | 66.49 | 45 |
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Lrrc75b | ENSMUSG00000046807 |
| rattus_norvegicus | Lrrc75b | ENSRNOG00000075066 |
Protein
Protein identifiers
Leucine-rich repeat-containing protein 75B — Q2VPJ9 (reviewed: Q2VPJ9)
Alternative names: Leucine-rich repeat-containing protein FAM211B
All UniProt accessions (3): F8WCG9, F8WCZ7, Q2VPJ9
UniProt curated annotations — full annotation on UniProt →
Function. May suppress myogenic differentiation by modulating MYOG expression and Erk1/2 signaling.
Similarity. Belongs to the LRRC75 family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q2VPJ9-1 | 1 | yes |
| Q2VPJ9-2 | 2 |
RefSeq proteins (1): NP_997527* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR032675 | LRR_dom_sf | Homologous_superfamily |
UniProt features (10 total): repeat 2, region of interest 2, compositionally biased region 2, splice variant 2, chain 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q2VPJ9-F1 | 73.05 | 0.37 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 66 (showing top):
ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN, SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_UP, MARSON_BOUND_BY_FOXP3_UNSTIMULATED, MIKKELSEN_MCV6_HCP_WITH_H3K27ME3, GSE13522_WT_VS_IFNAR_KO_SKING_T_CRUZI_Y_STRAIN_INF_DN, GSE13522_CTRL_VS_T_CRUZI_Y_STRAIN_INF_SKIN_IFNAR_KO_UP, EBNA1BP2_TARGET_GENES, ZBTB12_TARGET_GENES, GSE10239_MEMORY_VS_KLRG1INT_EFF_CD8_TCELL_UP, MIR636, GSE13306_TREG_VS_TCONV_LAMINA_PROPRIA_DN, GSE14308_TH1_VS_INDUCED_TREG_UP, GSE14308_NAIVE_CD4_TCELL_VS_INDUCED_TREG_UP, DESCARTES_MAIN_FETAL_DUCTAL_CELLS, PSIP1_TARGET_GENES
GO Biological Process (0):
GO Molecular Function (0):
GO Cellular Component (0):
Protein interactions and networks
STRING
96 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| LRRC75B | C22orf15 | Q8WYQ4 | 718 |
| LRRC75B | DRICH1 | Q6PGQ1 | 622 |
| LRRC75B | GUCD1 | Q96NT3 | 591 |
| LRRC75B | PROSER2 | Q86WR7 | 581 |
| LRRC75B | ZNF70 | Q9UC06 | 571 |
| LRRC75B | GSTT4 | A0A1W2PR19 | 567 |
| LRRC75B | DDTL | A6NHG4 | 542 |
| LRRC75B | RGL4 | Q8IZJ4 | 507 |
| LRRC75B | STOML1 | Q9UBI4 | 448 |
| LRRC75B | SPECC1L | Q69YQ0 | 434 |
| LRRC75B | UPB1 | Q9UBR1 | 419 |
| LRRC75B | H7C1H1 | H7C1H1 | 418 |
| LRRC75B | SLC2A11 | Q9BYW1 | 417 |
| LRRC75B | VPREB3 | Q9UKI3 | 395 |
| LRRC75B | CHRNA1 | P02708 | 384 |
IntAct
0 interactions, top by confidence:
BioGRID (2): LRRC75B (Affinity Capture-RNA), LRRC75B (Positive Genetic)
ESM2 similar proteins: A0A1W2PP97, A6NLX4, A6QNY1, P0DJK0, P12838, P13207, P22389, P22749, P23943, P29473, P29474, P55056, P70313, P79209, P97270, P98162, Q1RMT9, Q28969, Q2TAL6, Q2VPJ9, Q4TUC0, Q566C8, Q5BIR3, Q5JTB6, Q5NRP8, Q5RCS3, Q5SPX3, Q5XIX0, Q62600, Q64322, Q7TMJ8, Q7TPD7, Q7TSF4, Q80TT8, Q867D0, Q8BZT7, Q8C8N3, Q8K1T4, Q8K4Z2, Q8MJW9
Diamond homologs: Q2VPJ9, Q7TPD7, Q7TSF4, Q8NAA5, P78395
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
1 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 1 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1450 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 22:24588209:CTTA:C | donor_loss | 1.0000 |
| 22:24588210:TTA:T | donor_loss | 1.0000 |
| 22:24588211:TA:T | donor_loss | 1.0000 |
| 22:24588212:A:AC | donor_gain | 1.0000 |
| 22:24588212:A:AG | donor_loss | 1.0000 |
| 22:24588213:C:CC | donor_gain | 1.0000 |
| 22:24588213:CCAG:C | donor_gain | 1.0000 |
| 22:24588227:T:TA | donor_gain | 1.0000 |
| 22:24588325:TAGTC:T | acceptor_gain | 1.0000 |
| 22:24588327:GTC:G | acceptor_gain | 1.0000 |
| 22:24588328:TC:T | acceptor_gain | 1.0000 |
| 22:24588329:CC:C | acceptor_gain | 1.0000 |
| 22:24588329:CCTG:C | acceptor_loss | 1.0000 |
| 22:24588330:C:CC | acceptor_gain | 1.0000 |
| 22:24588331:T:G | acceptor_loss | 1.0000 |
| 22:24589817:TCA:T | donor_loss | 1.0000 |
| 22:24589820:C:CG | donor_loss | 1.0000 |
| 22:24589820:CCTT:C | donor_gain | 1.0000 |
| 22:24589945:AGGTC:A | acceptor_gain | 1.0000 |
| 22:24589946:GGTC:G | acceptor_gain | 1.0000 |
| 22:24589948:TC:T | acceptor_gain | 1.0000 |
| 22:24589949:CCTG:C | acceptor_gain | 1.0000 |
| 22:24589959:G:C | acceptor_gain | 1.0000 |
| 22:24589959:G:GC | acceptor_gain | 1.0000 |
| 22:24592822:C:CA | donor_gain | 1.0000 |
| 22:24592852:C:CA | donor_gain | 1.0000 |
| 22:24586412:C:CC | acceptor_gain | 0.9900 |
| 22:24588207:CCCTT:C | donor_loss | 0.9900 |
| 22:24588326:AGTC:A | acceptor_gain | 0.9900 |
| 22:24589819:A:AC | donor_gain | 0.9900 |
AlphaMissense
1980 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 22:24586267:G:C | F189L | 0.979 |
| 22:24586267:G:T | F189L | 0.979 |
| 22:24586269:A:G | F189L | 0.979 |
| 22:24586120:G:C | F238L | 0.945 |
| 22:24586120:G:T | F238L | 0.945 |
| 22:24586122:A:G | F238L | 0.945 |
| 22:24592927:A:G | I38T | 0.940 |
| 22:24586087:G:C | N249K | 0.922 |
| 22:24586087:G:T | N249K | 0.922 |
| 22:24586270:G:C | S188R | 0.919 |
| 22:24586270:G:T | S188R | 0.919 |
| 22:24586272:T:G | S188R | 0.919 |
| 22:24586121:A:G | F238S | 0.915 |
| 22:24586180:G:C | N218K | 0.908 |
| 22:24586180:G:T | N218K | 0.908 |
| 22:24586184:C:A | G217V | 0.907 |
| 22:24586090:G:C | N248K | 0.905 |
| 22:24586090:G:T | N248K | 0.905 |
| 22:24592940:A:G | W34R | 0.884 |
| 22:24592940:A:T | W34R | 0.884 |
| 22:24592936:A:T | L35H | 0.883 |
| 22:24586196:A:T | L213H | 0.880 |
| 22:24588286:A:T | L117H | 0.879 |
| 22:24586196:A:G | L213P | 0.876 |
| 22:24588286:A:G | L117P | 0.876 |
| 22:24586091:T:A | N248I | 0.867 |
| 22:24586107:A:G | W243R | 0.867 |
| 22:24586107:A:T | W243R | 0.867 |
| 22:24592927:A:C | I38S | 0.864 |
| 22:24586190:A:T | L215H | 0.859 |
dbSNP variants (sampled 300 via entrez): RS1000232388 (22:24588993 C>T), RS1000266797 (22:24589237 A>G), RS1000616149 (22:24587452 C>T), RS1000643265 (22:24593127 A>G), RS1001009331 (22:24585860 T>C), RS1001230668 (22:24589221 A>G), RS1001270770 (22:24590883 C>T), RS1001283155 (22:24589457 G>A), RS1001711695 (22:24585637 G>A), RS1001837618 (22:24585136 C>T), RS1002179047 (22:24594113 C>T), RS1002278377 (22:24592496 C>G), RS1002313012 (22:24586539 C>G,T), RS1002413627 (22:24586703 G>A,C), RS1002721252 (22:24594350 C>T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
4 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST000248_7 | Liver enzyme levels | 4.000000e-11 |
| GCST001234_7 | Gamma glutamyl transpeptidase | 7.000000e-53 |
| GCST002481_6 | Acne (severe) | 6.000000e-07 |
| GCST90013407_1 | Liver enzyme levels (gamma-glutamyl transferase) | 1.000000e-300 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004532 | serum gamma-glutamyl transferase measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
33 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | decreases expression, increases methylation | 2 |
| aristolochic acid I | decreases expression | 1 |
| GSK-J4 | decreases expression | 1 |
| afuresertib | increases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| bisphenol A | increases expression | 1 |
| sodium arsenite | decreases expression | 1 |
| abrine | decreases expression | 1 |
| jinfukang | affects cotreatment, increases expression | 1 |
| Resveratrol | affects cotreatment, decreases expression | 1 |
| Sunitinib | increases expression | 1 |
| Zoledronic Acid | decreases expression | 1 |
| Vorinostat | decreases expression | 1 |
| Air Pollutants | increases abundance, increases expression | 1 |
| Cadmium | decreases expression, increases abundance | 1 |
| Calcitriol | increases expression, affects cotreatment | 1 |
| Cisplatin | affects cotreatment, increases expression | 1 |
| Estradiol | affects cotreatment, increases expression | 1 |
| Niclosamide | increases expression | 1 |
| Plant Extracts | affects cotreatment, decreases expression | 1 |
| Smoke | decreases expression | 1 |
| Testosterone | affects cotreatment, increases expression | 1 |
| Thimerosal | decreases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Tretinoin | decreases expression | 1 |
| Valproic Acid | affects expression | 1 |
| 1-Methyl-4-phenylpyridinium | increases expression | 1 |
| Cyclosporine | decreases expression | 1 |
| Cadmium Chloride | decreases expression, increases abundance | 1 |
| Palmitic Acid | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.